More than 10,000 individuals with TSC and their families in whom pathogenic variants have been identified, 26% of probands have a pathogenic variant in TSC1 and 74% have a pathogenic variant in TSC2.[8] To date, this mutation has been reported as pathogenic. The gene discussed is TSC2; the disease is tuberous sclerosis.